发明申请
US20120178750A1 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
审中-公开
烟酸受体激动剂，包含这些化合物的组合物和治疗方法
- 专利标题： Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
- 专利标题（中）： 烟酸受体激动剂，包含这些化合物的组合物和治疗方法
-
申请号： US13423618申请日： 2012-03-19
-
公开(公告)号： US20120178750A1公开(公告)日： 2012-07-12
- 发明人: Subharekha Raghavan , Steven L. Colletti , Fa-Xiang Ding , Hong Shen , James R. Tata , Ashley Rouse Lins , Abigail Lee Smenton , Weichun Chen , Darby Rye Schmidt , George Scott Tria
- 申请人： Subharekha Raghavan , Steven L. Colletti , Fa-Xiang Ding , Hong Shen , James R. Tata , Ashley Rouse Lins , Abigail Lee Smenton , Weichun Chen , Darby Rye Schmidt , George Scott Tria
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; A61K31/423 ; A61K31/429 ; A61K31/41 ; A61K31/426 ; A61K31/427 ; A61K31/403 ; A61K31/4375 ; A61K31/437 ; A61K31/538 ; A61K31/4196 ; A61P9/10 ; A61P3/06 ; A61P3/10 ; A61P3/00 ; A61K31/196
摘要：
The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.